The inhibitor of growth 1 (ING1) proteins suppress angiogenesis and differentially regulate angiopoietin expression in glioblastoma cells

Oncology Research

Volumn 18, Issue 2-3, 2009, Pages 95-105

  Tallen, Gesche ^a   Farhangi, Sonja ^a   Tamannai, Mona ^a   Holtkamp, Nikola ^a   Mangoldt, Dorothea ^a   Shah, Sitar ^b   Suzuki, Keiko ^b   Truss, Matthias ^a   Henze, Guenter ^a   Riabowol, Karl ^b   Von Deimling, Andreas ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiogenesis; Angiopoietins; Glioblastoma multiforme; Inhibitor of growth 1 (ING1)

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 4; BETA ACTIN; GENE PRODUCT; INHIBITOR OF GROWTH 1 PROTEIN; INTERLEUKIN 8; ISOPROTEIN; PROTEIN P33 ING1B; PROTEIN P47 ING1A; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; ING1 PROTEIN, HUMAN; NUCLEAR PROTEIN; SIGNAL PEPTIDE; TUMOR SUPPRESSOR PROTEIN; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; CHORIOALLANTOIS; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE OVEREXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; ING1 GENE; ING1A GENE; ING1B GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; ANIMAL; CHICK EMBRYO; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; TUMOR CELL LINE; VASCULARIZATION;

ANGIOPOIETINS; ANIMALS; CELL LINE, TUMOR; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 75649106449     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504009789954645     Document Type: Article

References (52)

1. Garkavtsev, I.; Kazarov, A.; Gudkov, A.; Riabowol, K. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nat. Genet. 14(4):415-420; 1996.
2. Feng, X.; Hara, Y.; Riabowol, K. Different HATS of the ING1 gene family. Trends Cell Biol. 12:532-538; 2002.
3. Gong, W.; Suzuki, K.; Russell, M.; Riabowol, K. Function of the ING family of PHD proteins in cancer. Int. J. Biochem. Cell Biol. 37:1054-1065; 2005.
4. Abad, M.; Menéndez, C.; Füchtbauer, A.; Serrano, M.; Füchtbauer, E. M.; Palmero, I. Ing1 mediates p53 accumulation and chromatin modification in response to oncogenic stress. J. Biol. Chem. 282(42):31060-31067; 2007.
5. Russell, M.; Berardi, P.; Gong, W.; Riabowol, K. Grow-ING, Age-ING and Die-ING: ING proteins link cancer, carcisenescence and apoptosis. Exp. Cell Res. 312(7):951-961; 2006.
6. Garkavtsev, I.; Demetrick, D.; Riabowol, K. Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (ING1). Cytogenet. Cell Genet. 76: 176-178; 1997.
7. Gunduz, M.; Ouchida, M.; Fukushima, K.; Hanafusa, H.; Etani, T.; Nishioka, S.; Nishizaki, K.; Shimizu, K. Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas. Cancer Res. 60:3143-3146; 2000.
8. Walzak, A. A.; Veldhoen, N.; Feng, X.; Riabowol, K.; Helbing, C. C. Expression profiles of mRNA transcript variants encoding the human inhibitor of growth tumor suppressor gene family in normal and neoplastic tissues. Exp. Cell Res. 314(2):273-285; 2008.
9. Cheung, Jr., K. J.; Mitchell, D.; Lin, P.; Li, G. The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA. Cancer Res. 61:4974-4977; 2001.
10. Scott, M.; Boisvert, F. M.; Vieyra, D.; Johnston, R. N.; Bazett-Jones, D. P.; Riabowol, K. UV induces nucleolar translocation of ING1 through two distinct nucleolar targeting sequences. Nucleic Acids Res. 29:2052-2058; 2001.
11. Vieyra, D.; Loewith, R.; Scott, M.; Bonnefin, P.; Boisvert, F. M.; Cheema, P.; Pastyryeva, S.; Meijer, M.; Johnston, R. N.; Bazett-Jones, D. P.; McMahon, S.; Cole, M. D.; Young, D.; Riabowol, K. Human ING1 proteins differentially regulate histone acetylation. J. Biol. Chem. 277: 29832-29839; 2002.
12. He, G. H.; Helbing, C. C.; Wagner, M. J.; Sensen, C. W.; Riabowol, K. Phylogenetic analysis of the ING family of PHD finger proteins. Mol. Biol. Evol. 22:104-116; 2005.
13. Martin, D. G. E.; Baetz, K.; Shi, X.; Walter, K. L.; MacDonald, V. E.; Wlodarski, M. J.; Gozani, O.; Hieter, P.; Howe, L. The Yng1p PHD finger is a methyl-histone binding module that recognizes lysine 4 methylated histone H3. Mol. Cell. Biol. 26:7871-7879; 2006.
14. Pena, P. V.; Davrazou, F.; Shi, X.; Walter, K. L.; Verkhusha, V. V.; Gozani, O.; Zhao, R.; Kutateladze, T. G. Molecular mechanism of H3K4me3 recognition by plant homeodomain of ING2. Nature 442:100-103; 2006.
15. Shi, X.; Hong, T.; Walter, K. L.; Ewalt, M.; Michishita, E.; Hung, T.; Carney, D.; Peña, P.; Lan, F.; Kaadige, M. R.; Lacoste, N.; Cayrou, C.; Davrazou, F.; Saha, A.; Cairns, B. R.; Ayer, D. E.; Kutateladze, T. G.; Shi, Y.; Côté, J.; Chua, K. F.; Gozani, O. ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 442:96-99; 2006.
16. Palacios, A.; Garcia, P.; Padro, D.; Lopez-Hernandez, E.; Martin, I.; Blanco, F. J. Solution structure and NMR characterization of the binding to methylated histone tails of the plant homeodomain finger of the tumour suppressor ING4. FEBS Lett. 580:6903-6908; 2006.
17. Kaadige, M. R.; Ayer, D. E. The polybasic region that follows the plant homeodomain zinc finger 1 of Pf1 is necessary and sufficient for specific phosphoinositide binding. J. Biol. Chem. 281:28831-28836; 2006.
18. Vieyra, D.; Senger, D. L.; Toyama, T.; Muzik, H.; Brasher, P. M.; Johnston, R. N.; Riabowol, K.; Forsyth, P. A. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors. Clin. Cancer Res. 9:5952-5961; 2003.
19. Tallen, G.; Kaiser, I.; Krabbe, S.; Lass, U.; Hartmann, C.; Henze, G.; Riabowol, K.; von Deimling, A. No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma. Int. J. Cancer 109:476-479; 2004.
20. Folkman, J. Tumor angiogenesis: Therapeutic implications. N. Engl. J. Med. 285:1182-1186; 1971.
21. Folkman, J. Angiogenesis. In: Harrison's textbook of internal medicine, 15th ed. New York: McGraw-Hill; 2001: 517-530.
22. Folkman, J. Angiogenesis and apoptosis. Semin. Cancer Biol. 13:159-167; 2003.
23. Van Meir, E. G.; Polverini, P. J.; Chazin, V. R.; Su Huang, H. J.; de Tribolet, N.; Cavenee, W. K. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat. Genet. 8:171-176; 1994.
24. Tse, V.; Yung, Y.; Santarelli, J. G.; Juan, D.; Hsiao, M.; Haas, M.; Harsh, 4th, G.; Silverberg, G. Effects of tumor suppressor gene (p53) on brain tumor angiogenesis and expression of angiogenic modulators. Anticancer Res. 24: 1-10; 2004.
25. Louis, D. N.; Ohgaki, H.; Wiestler, O. D.; Cavenee, W. K.; Burger, P. C.; Jouvet, A.; Scheithauer, B. W.; Kleihues, P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114(2):97-109; 2007.
26. Kargiotis, O.; Rao, J. S.; Kyritsis, A. P. Mechanisms of angiogenesis in gliomas. J. Neurooncol. 78:281-293; 2006.
27. Leon, S. P.; Folkerth, R. D.; Black, P. M. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77:362-372; 1996.
28. Koga, K.; Todaka, T.; Morioka, M.; Hamada, J.; Kai, Y.; Yano, S.; Okamura, A.; Takakura, N.; Suda, T.; Ushio, Y. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis. Cancer Res. 61:6248-6254; 2001.
29. Lund, E. L.; Høg, A.; Olsen, M. W. B.; Hansen, L. T.; Engelholm, S. A.; Kristjansen, P. E. G. Differential regulation of VEGF, HIF1α and angiopoietin-1, -2 and -4 by hypoxia and ionizing radiation in human glioblastoma. Int. J. Cancer 108:833-838; 2004.
30. Stiver, S. L. Angiogenesis and its role in the behavior of astrocytic brain tumors. Front. Biosci. 9:3105-3123; 2004.
31. Reiss, Y.; Machein, M. R.; Plate, K. H. The role of angiopoietins during angiogenesis in gliomas. Brain Pathol. 15: 311-317; 2005.
32. Plate, K. H.; Breier, G.; Weich, H. A.; Risau, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845-848; 1992.
33. Suri, C.; McLain, J.; Thurston, G.; McDonald, D. M.; Zhou, H.; Oldmixon, E. H.; Sato, T. N.; Yancopoulos, G. D. Increased vascularization in mice overexpressing angiopoietin-1. Science 282:468-471; 1998.
34. Valenzuela, D. M.; Griffiths, J. A.; Rojas, J.; Aldrich, T. H.; Jones, P. F.; Zhou, H.; McClain, J.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Huang, T.; Papadopoulos, N.; Maisonpierre, P. C.; Davis, S.; Yancopoulos, G. D. Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans. Proc. Natl. Acad. Sci. USA 96: 1904-1909; 1999.
35. Nakayama, T.; Yoshizaki, A.; Kawahara, N.; Ohtsuru, A.; Wen, C. Y.; Fukuda, E.; Nakashima, M.; Sekine, I. Expression of Tie-1 and 2 receptors, and angiopoietin-1, 2 and 4 in gastric carcinoma, immunohistochemical analyses and correlation with clinicopathological factors. Histopathology 44:232-239; 2004.
36. Olsen, M. W. B.; Ley, C. D.; Junker, N.; Hansen, A. J.; Lund, E. L.; Kristjansen, P. E. G. Angiopoietin-4 inhibits angiogenesis and reduces interstitial fluid pressure. Neoplasia 8:364-372; 2006.
37. Garkavtsev, I.; Kozin, S. V.; Chernova, O.; Xu, L.; Winkler, F.; Brown, E.; Barnett, G. H.; Jain, R. K. The candidate tumor suppressor ING4 regulates brain tumour growth and angiogenesis. Nature 428:328-332; 2004.
38. Ozer, A.; Wu, L. C.; Bruick, R. K. The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF). Proc. Natl. Acad. Sci. USA 102: 7481-7486; 2005.
39. Colla, S.; Tagliaferri, S.; Morandi, F.; Lunghi, P.; Donofrio, G.; Martorana, D.; Mancini, C.; Lazzaretti, M.; Mazzera, L.; Ravanetti, L.; Bonomini, S.; Ferrari, L.; Miranda, C.; Ladetto, M.; Neri, T. M.; Neri, A.; Greco, A.; Mangoni, M.; Bonati, A.; Rizzoli, V.; Giuliani, N. The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1α (HIF-1α) activity: Involvement in myeloma- induced angiogenesis. Blood 110(13):4464-4475; 2007.
40. Cheung, Jr., K. J.; Li, G. The tumour suppressor p33ING1 does not regulate migration and angiogenesis in melanoma cells. Int. J. Oncol. 21:1361-1365; 2002.
41. Tallen, U. G.; Truss, M.; Kunitz, F.; Wellmann, S.; Unryn, B.; Sinn, B.; Lass, U.; Krabbe, S.; Holtkamp, N.; Hagemeier, C.; Wurm, R.; Henze, G.; Riabowol, K.; von Deimling, A. Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death. J. Neurooncol. 86(1):23-30; 2008.
42. Boland, D.; Olineck, V.; Bonnefin, P.; Vieyra, D.; Parr, E.; Riabowol, K. A panel of CAb antibodies recognize endogenous and ectopically expressed ING1 protein. Hybridoma 19:161-165; 2000.
43. Ishii, N.; Maier, D.; Merlo, A.; Tada, M.; Sawamura, Y.; Diserens, A.-C.; Van Meir, E. G. Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol. 9:469-479; 1999.
44. Marimpietri, D.; Nico, B.; Vacca, A.; Mangieri, D.; Catarsi, P.; Ponzoni, M.; Ribatti, D. Synergistic inhibition of human neuroblastoma-related angiogenesis by vinblastine and rapamycin. Oncogene 24(45):6785-6795; 2005.
45. Schneiderhan, W.; Diaz, F.; Fundel, M.; Zhou, S.; Siech, M.; Hasel, C.; Möller, P.; Gschwend, J. E.; Seufferlein, T.; Gress, T.; Adler, G.; Bachem, M. G. Pancreatic stellate cells are an important source of MMP-2 in human pancreatic cancer and accelerate tumor progression in a murine xenograft model and CAM assay. J. Cell Sci. 120(3):512-519; 2007.
46. Vates, G. E.; Hashimoto, T.; Young, W. L.; Lawton, M. T. Angiogenesis in the brain during development: The effects of vascular endothelial growth factor and angiopoietin-2 in an animal model. J. Neurosurg. 103:136-145; 2005.
47. Hashimoto, T.; Wu, Y.; Lawton, M. T.; Yang, G. Y.; Barbaro, N. M.; Young, W. L. Coexpression of angiogenic factors in brain arteriovenous malformations. Neurosurgery 56:1058-1065; 2005.
48. Kichina, J. V.; Zeremski, M.; Aris, L.; Gurova, K. V.; Walker, E.; Franks, R.; Nikitin, A. Y.; Kiyokawa, H.; Gudkov, A. V. Targeted disruption of the mouse ing1 locus results in reduced body size, hypersensitivity to radiation and elevated incidence of lymphomas. Oncogene 25: 857-866; 2006.
49. Coles, A. H.; Liang, H.; Zhu, Z.; Marfella, C. G.; Kang, J.; Imbalzano, A. N.; Jones, S. N. Deletion of p37Ing1 in mice reveals a p53- independent role for Ing1 in the suppression of cell proliferation, apoptosis, and tumorigenesis. Cancer Res. 67:2054-2061; 2007.
50. Brat, D. J.; Bellail, A. C.; van Meir, E. G. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neurooncology 7:122-133; 2005.
51. Stratmann, A.; Risau, W.; Plate, K. H. Cell-type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am. J. Pathol. 153: 1459-1466; 1998.
52. Machein, M. R.; Knedla, A.; Knoth, R.; Wagner, S.; Neuschl, E.; Plate, K. H. Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model. Am. J. Pathol. 165:1557-1570; 2004.